Dividend increased approximately 8% and $581 million in share repurchases executed from a new $1.5 billion authorization.
Joshua T. Katz on the future of higher education.
The rheumatoid arthritis clinical trial analysis report delivers important insights into ongoing research of 80+ pipeline ...
Assumes all Partnership Units and unvested RSUs have been converted to shares of the Company's Class A common stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results